|
|
|
Insider
Information: |
Gilman Alfred G |
Relationship: |
Director |
City: |
Dallas |
State: |
TX |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
57,199 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$45,935,158 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
57,199 |
|
|
Total
Value |
$45,935,158 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Regeneron Pharmaceuticals Inc |
REGN |
Director |
2015-08-06 |
8,912 |
2003-09-11 |
0 |
Premium* |
|
Eli Lilly & Co |
LLY |
Director |
2013-11-29 |
48,287 |
2003-11-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
72 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2003-09-11 |
4 |
OE |
$6.00 |
$310,000 |
D/D |
45,000 |
30,000 |
|
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2003-09-11 |
4 |
A |
$0.00 |
$0 |
D/D |
12,975 |
12,975 |
|
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2003-09-11 |
4 |
S |
$21.40 |
$1,289,675 |
D/D |
(60,000) |
2,975 |
|
- |
|
LLY |
Eli Lilly & Co |
Director |
|
2003-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
700 |
8,168 |
|
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2003-12-18 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
27,975 |
|
- |
|
LLY |
Eli Lilly & Co |
Director |
|
2004-11-30 |
4 |
A |
$56.59 |
$39,613 |
D/D |
700 |
9,033 |
|
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2004-12-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
6,000 |
17,975 |
|
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2005-02-07 |
4 |
OE |
$6.00 |
$143,126 |
D/D |
23,646 |
36,621 |
|
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2005-02-07 |
4 |
AS |
$7.50 |
$177,345 |
D/D |
(23,646) |
17,975 |
|
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2005-02-28 |
4 |
AS |
$6.29 |
$134,317 |
D/D |
(21,354) |
17,975 |
|
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2005-02-28 |
4 |
OE |
$6.00 |
$128,124 |
D/D |
21,354 |
22,975 |
|
- |
|
LLY |
Eli Lilly & Co |
Director |
|
2005-11-30 |
4 |
A |
$50.51 |
$75,758 |
D/D |
1,500 |
10,781 |
|
- |
|
REGN |
Regeneron Pharmaceuticals... |
officerTitle |
|
2005-12-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
6,000 |
11,975 |
|
- |
|
REGN |
Regeneron Pharmaceuticals... |
officerTitle |
|
2006-01-06 |
4 |
OE |
$12.00 |
$109,200 |
D/D |
9,100 |
12,475 |
|
- |
|
REGN |
Regeneron Pharmaceuticals... |
officerTitle |
|
2006-01-06 |
4 |
S |
$15.94 |
$147,250 |
D/D |
(9,100) |
11,975 |
|
- |
|
REGN |
Regeneron Pharmaceuticals... |
officerTitle |
|
2006-01-06 |
4 |
OE |
$12.00 |
$10,800 |
D/D |
900 |
12,475 |
|
- |
|
REGN |
Regeneron Pharmaceuticals... |
officerTitle |
|
2006-01-06 |
4 |
S |
$16.33 |
$14,812 |
D/D |
(900) |
11,975 |
|
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2006-11-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
6,975 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Director |
|
2006-11-30 |
4 |
A |
$54.26 |
$144,983 |
D/D |
2,672 |
13,759 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2007-02-26 |
4 |
OE |
$9.88 |
$84,968 |
D/D |
8,600 |
7,575 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2007-02-26 |
4 |
AS |
$21.33 |
$184,518 |
D/D |
(8,600) |
6,975 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2007-02-26 |
4 |
OE |
$9.88 |
$13,832 |
D/D |
1,400 |
7,075 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2007-02-26 |
4 |
AS |
$21.53 |
$30,164 |
D/D |
(1,400) |
6,975 |
0 |
- |
|
LLY |
Eli Lilly & Co |
Director |
|
2007-11-30 |
4 |
A |
$51.06 |
$144,996 |
D/D |
2,840 |
17,024 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
Director |
|
2007-12-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,000 |
4,975 |
0 |
- |
|
72 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|